Illustrative image – not actual.
Merck Life Science has entered into a five-year partnership with Heavy Water Board, which operates under the Department of Atomic Energy (DAE) last month for the constant supply of heavy water, focused on non-nuclear applications of heavy water.
The pharamaceutical company expects to start the commercial production of deuterated compounds at its Bengaluru factory this month. With an emphasis on local production, further investment into the Jigani site in Bengaluru has already been planned and will be infused over the next one to three years.
By building heavy water processing capabilities, the drug major will drive expansion plans in India, and also cater to global markets for niche products, and export to Japan, Taiwan and South Korea in particular, depending on policies and specific business agreements.
These compounds assist drug formulation have slower pharmacokinetics and lesser toxicological side effects, whereas deuterium-labelled reagents aid in improving the lifespan of semiconductors.
